Washington
+919405476170
Washington
+919405476170
+919359902383

Erlotinib Tablets BP, 100 mg, 150mg : Kingston, Jamaica, peru, Paraguay,United States, Washington, D.C.; United Kingdom, London; Germany, Berlin; France, Paris; Italy, Rome; Spain, Madrid; Netherlands, Amsterdam; Belgium, Brussels; Switzerland, Bern; Poland, Warsaw; Hungary, Budapest; Australia, Canberra; New Zealand, Wellington; Singapore; Malaysia, Kuala Lumpur; Indonesia, Jakarta; Vietnam, Hanoi; Philippines, Manila; Thailand, Bangkok. United Arab Emirates, Abu Dhabi; Saudi Arabia, Riyadh; Qatar, Doha; Oman, Muscat; Kuwait, Kuwait City; South Africa, Pretoria; Nigeria, Abuja; Peru, Lima; Argentina, Buenos Aires; Brazil, Brasília; Mexico, Mexico City; Chile, Santiago; Colombia, Bogotá


Erlotinib Tablets BP, 100 mg, 150mg

Product/Composition: Erlotinib Tablets BP
Pharmaceutical Form: Tablets
Strength/Pack: 100mg, 150mg

Erlotinib tablets are used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms: Non-Small Cell Lung Cancer, Chemotherapy, Pancreatic Cancer. The following is a list of possible side effects that may occur in medicines that contain erlotinib. This is not a comprehensive list. These side effects are possible but do not always occur. Some of the side effects may be rare but serious. Consult your doctor if you observe any of the following side effects, especially if they do not go away. Dry skin, cough, fatigue, Alopecia, nausea, and folliculitis.


Key Product Information


SpecificationDetails
Brand NameErlotinib Tablets BP
Generic NameErlotinib
Strength150 mg
FormFilm-coated oral tablet
Drug ClassEGFR Tyrosine Kinase Inhibitor
Therapy TypeTargeted Oncology Treatment
IndicationNon-small cell lung cancer (NSCLC)
RouteOral
PrescriptionRequired
Supply TypeExport, Wholesale, Hospital Supply


EGFR Lung Cancer Medicine Exporter: United States, Washington, D.C.; United Kingdom, London; Germany, Berlin; France, Paris; Italy, Rome; Spain, Madrid; Netherlands, Amsterdam; Belgium, Brussels; Switzerland, Bern; Poland, Warsaw; Hungary, Budapest; Australia, Canberra; New Zealand, Wellington; Singapore; Malaysia, Kuala Lumpur; Indonesia, Jakarta; Vietnam, Hanoi; Philippines, Manila; Thailand, Bangkok. United Arab Emirates, Abu Dhabi; Saudi Arabia, Riyadh; Qatar, Doha; Oman, Muscat; Kuwait, Kuwait City; South Africa, Pretoria; Nigeria, Abuja; Peru, Lima; Argentina, Buenos Aires; Brazil, Brasília; Mexico, Mexico City; Chile, Santiago; Colombia, Bogotá


Therapeutic Advantages


Erlotinib provides a targeted approach for treating cancers driven by EGFR mutations.


Benefits include:

  • Inhibits EGFR-driven tumor growth
  • Helps slow disease progression
  • Oral administration for patient convenience
  • Suitable for outpatient treatment plans
  • Reduces need for intravenous therapy
  • Supports treatment of advanced or metastatic NSCL


Treatment Guidelines & Precautions


✔ Follow Prescribed Schedule

Maintain consistent timing and fasting conditions.

✔ Avoid Self-Medication Changes

Do not skip, double, or split doses without medical advice.

✔ Smoking Advisory

Smoking may reduce drug effectiveness—inform your doctor.

✔ Drug Interactions

Avoid unsupervised use of:

  • Antacids
  • Proton pump inhibitors
  • H2 blockers

✔ Regular Monitoring

Routine checks may include:

  • Liver function tests
  • Skin reactions
  • Respiratory symptoms
  • Eye health

✔ Full Disclosure

Inform your doctor about all medications, supplements, and herbal products.


Frequently Asked Questions (FAQs)


1. What is Erlotinib 150 mg used for?

It is used for treating advanced or metastatic non-small cell lung cancer in patients with EGFR mutations.

2. Can Erlotinib be taken with food?

No. It must be taken on an empty stomach to ensure proper absorption.

3. Can the tablet be crushed?

No. Tablets should be taken whole unless advised otherwise by a healthcare professional.

4. Is international procurement allowed?

Yes, licensed hospitals and distributors can import Erlotinib through authorized exporters, subject to regulations.


Medical Disclaimer 


Erlotinib is a prescription-only oncology medication. Treatment decisions, dosage, and monitoring must be handled by a qualified healthcare professional. This content is for informational and trade purposes only and should not replace medical advice or official prescribing guidelines.


#Erlotinib #Erlotinib150mg #EGFRInhibitor #TargetedTherapy #LungCancerTreatment #OncologyMedicine #CancerDrugSupplier #PharmaExporter #GlobalPharma #HospitalSupply #MedicalDistributor #KingstonJamaica #JakartaIndonesia #OncologySupplier #BulkMedicine #HealthcareSupply #CancerCare #PharmaceuticalExport #ErnestI

 


  • Buy Erlotinib 150 mg online
  • Erlotinib supplier Jamaica
  • Erlotinib distributor Indonesia
  • EGFR inhibitor exporter
  • Lung cancer medicine supplier
  • Oncology drug wholesaler
  • Erlotinib bulk supplier
  • Cancer tablets exporter India
  • Hospital oncology procurement
  • Targeted therapy supplier


  • 📞 Contact Ernest Impex – Pharmaceutical Exporter from India

    [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.]


    🌐 Websites:

    www.ernestimpex.com

    www.ernestpharmaceuticals.com

    www.oncologuymediciensupplier.com

    www.ernestvision.com

    📧 Email: exports@ernestpharmaceuticals.com

    📦 Business Type: Exporter | Bulk Supplier | Distributor

  • 📲 WhatsApp: +91 9405476170  
  •    https://wa.me/message/V2MEXZ6ZAYY5B1  
  •  2026-07-15T06:50:30

    Other Pages

    View all pages